Home » NMP22 BLADDERCHEK TEST TO BE INTRODUCED TO U.S. GYNECOLOGISTS
NMP22 BLADDERCHEK TEST TO BE INTRODUCED TO U.S. GYNECOLOGISTS
Matritech, a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, announced today that the NMP22 BladderChek Test will be exhibited for the first time at a U.S. gynecology conference. The test will be featured in an exhibit at the American College of Obstetricians and Gynecologists (ACOG) annual meeting in Washington, D.C.
Business Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May